Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAST-A: Vasopressin and Steroids in Cardiac Arrest
NCT05139849Phase 3Recruiting
- Sponsor
- TioHundra
- Start
- Nov 2021
- Primary completion
- Jan 2027
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin, methylprednisolone, hydrocortisone in cardiac arrest (SCA), sponsored by TioHundra. Started Nov 2021; status: recruiting.
02
Drugs
vasopressinmethylprednisolonehydrocortisone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05139849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05139849.